Unnatural Amino Acids

Published: Apr, 2015 | Pages: 1280 | Publisher: RESEARCH IMPACT TECHNOLOGIES
Industry: Biotechnology | Report Format: Electronic (PDF)

This market insight report on Unnatural Amino Acids gives an insight into the different types of Unnatural Amino Acids (ß-Amino Acids, ß-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other. The study includes estimations and predictions for 2005 -2020 for the global Unnatural Amino Acids market by type and applications. Regional Analysis is covered separately for North America (United States and Canada); Europe (UK, Germany, Switzerland, Italy, The Netherlands, and Rest of Europe); Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific); and Rest of World. The text is complemented with graphical representations of 318 exhibits. Business profiles of 61 major companies are discussed in the report. The report serves as a guide to global Unnatural Amino Acids industry covering more than 1100 companies that are engaged in Unnatural Amino Acids R&D, synthesis, discovery, testing and supply of derivatives, products and services. Compilation of Worldwide Patents and Research related to Unnatural Amino Acids is also provided. Information related to industrial activity, corporate developments, research trends, product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

 Table of Content

1. SCOPE AND METHODOLOGY	1
2. REPORT SYNOPSIS	4
2.1 Unnatural Amino Acids – An Introduction	4
Amino Acids	4
Types of Amino Acids	5
Essential Amino Acids	5
Non-Essential Amino Acids	5
Proteinogenic Amino Acids	5
Unnatural Amino acids	5
Non-Proteinogenic Amino Acids	6
Non-Standard Amino Acids	6
Synthetic Unnatural Amino Acids	6
2.2 Segmentation of Unnatural Amino Acids	7
Exhibit 1. Segmentation of Unnatural Amino Acids Market by Type and Application	7
Unnatural Amino Acids - Definitions, Important Facts & Figures	7
β-Amino Acids & Derivatives	7
β-Amino acids	7
β-Alanine	7
Synonyms	8
Molecular Formula	8
Molecular Weight	8
Structure	8
Synthesis	8
IUPAC Name	8
β-methylphenylalanine	8
β-Amino Alcohols	8
Synthesis	8
Cyclic Amino Acids & Derivatives	9
Cyclic β-Amino Acids	9
Cyclic Unnatural α-Amino Acids	9
D-Cycloserine	9
Synonyms	9
Molecular Formula	9
Molecular Weight	9
Structure	9
IUPAC Name	9
D-Amino Acids & Derivatives	9
D-Cysteine	10
Synonyms	10
Molecular Formula	10
Molecular Weight	10
Structure	10
Synthesis	11
IUPAC Name	11
D-Serine	11
Synonyms	11
Molecular Formula	11
Molecular Weight	11
Structure	11
IUPAC Name	12
D-Proline	12
Synonyms	12
Molecular Formula	12
Molecular Weight	12
Structure	13
IUPAC Name	13
D-Valine	13
Synonyms	13
Molecular Formula	14
Molecular Weight	14
Structure	14
Synthesis	14
IUPAC Name	14
D-Alanine	14
Synonyms	14
Molecular Formula	15
Molecular Weight	15
Structure	15
Synthesis	15
IUPAC Name	15
D-Phenylalanine	15
Synonyms	16
Molecular Formula	16
Molecular Weight	16
Synthesis	16
IUPAC Name	16
D-Citrulline /D-Citrulene	16
Synonyms	16
Molecular Formula	16
Molecular Weight	16
Structure	16
IUPAC Name	17
D-Tryptophan	17
Synonyms	17
Molecular Formula	17
Molecular Weight	17
Structure	17
Synthesis	17
IUPAC Name	17
D-Lysine	18
Synonyms	18
Molecular Formula	18
D-Leucine	18
Synonyms	18
Molecular Formula	18
Molecular Weight	18
Structure	18
D-Histidine	19
Histidine	19
Synonyms	19
Molecular Formula	19
Molecular Weight	19
IUPAC Name	19
D-Glutamic Acid	19
Synonyms	20
Molecular Formula	20
Molecular Weight	20
Structure	20
D-Methionine	20
Synonyms	21
Molecular Formula	21
Molecular Weight	21
D-Aspartic Acid	21
Neurotransmitter	21
Synonyms	21
Molecular Formula	22
Molecular Weight	22
Structure	22
IUPAC Name	22
D-Tyrosine	22
Synonyms	22
Molecular Formula	23
Molecular Weight	23
Structure	23
IUPAC Name	23
D-Arginine	23
D-Threonine	23
Synonyms	24
Molecular Formula	24
Molecular Weight	24
Structure	24
IUPAC Name	24
D-Phenylglycine	24
Synonyms	24
Molecular Formula	25
Molecular Weight	25
Structure	25
IUPAC Name	25
D-p-hydroxy phenylglycine	25
Synonyms	25
Molecular Formula	25
Molecular Weight	25
Synthesis	25
D-2-Chlorophenylglycine	25
Synonyms	26
Molecular Formula	26
Molecular Weight	26
Structure	26
D-Penicillamine	26
Synonyms	26
Molecular Formula	26
Molecular Weight	26
Synthesis	26
IUPAC Name	26
DL-Amino Acids & Derivatives	27
DL-Alanine	27
Synonyms	27
Molecular Formula	27
Molecular Weight	27
Structure	27
Synthesis	27
Biosynthesis	27
Chemical Synthesis	28
IUPAC Name	28
DL-Methionine	28
Synonyms	28
Molecular Formula	28
Molecular Weight	28
Structure	28
IUPAC Name	29
DL-Phenylalanine	29
Synonyms	29
Molecular Formula	29
Molecular Weight	29
IUPAC Name	29
L-Amino Acid Derivatives	29
L-Homophenylalanine	29
Synonyms	30
Molecular Formula	30
Molecular Weight	30
Structure	30
Synthesis	30
IUPAC Name	30
L-Dopa	30
Synonyms	30
Molecular Formula	30
Molecular Weight	31
Structure	31
Synthesis	31
Electroenzymatic synthesis of L-Dopa	31
IUPAC Name	31
L-p-hydroxy phenylglycine	31
Other	31
Gamma-Amino Butyric Acid (GABA)	31
Synonyms	32
Molecular Formula	32
Molecular Weight	32
Structure	32
IUPAC Name	32
Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)	32
Molecular Formula	32
Molecular Weight	32
IUPAC Name	32
Synthetic α-Amino Acids	32
L-Thyroxine	32
Molecular Formula	32
Molecular Weight	33
Structure	33
IUPAC Name	33
3,5,3',5'-Tetraiodo-L-thyronine	33
Levothyroxine Recommendations	34
L-Thyroxine Associated side effects	34
L-Thyroxine for Veterinary application	34
Synthroid	34
FDA Guidelines	35
Boc-Protected Amino Acids	35
Fmoc-Protected Amino Acids	35
Synthetic Biology – An Overview	35
Unnatural Amino Acids and Biochemistry	36
Unnatural Amino Acids and Chirality	37
Unnatural Amino Acids – The Future of the Pharmaceutical Industry	38
2.3 Global Market Analysis	39
Exhibit 2. Unnatural Amino Acids - Global Historic Value Market (2005-2010) in US$ Million	40
Exhibit 3. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011-2020) in US$ Million	41
Exhibit 4. Unnatural Amino Acids - Global Historic Volume Market (2005-2010) in Million Metric Tons	42
Exhibit 5. Unnatural Amino Acids - Global Volume Market Estimations & Predictions (2011-2020) in Million Metric Tons	43
Exhibit 6. List of Global Major Unnatural Amino Acids Companies	43
3. MARKET DYNAMICS	46
3.1 Unnatural Amino Acids – A Market Overview	46
Anti-Infectives – Antiviral and Antibacterial Drugs	46
Cephalosporins Market	47
Regulatory Guidelines for Drugs	50
Sweeteners	51
Agrochemicals	51
3.2 Global Unnatural Amino Acids Market	53
Exhibit 7. Unnatural Amino Acids - Global Historic Value Market (2005-2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	53
Exhibit 8. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	54
Exhibit 9. Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	55
3.3 North American Unnatural Amino Acids Market	56
North American Unnatural Amino Acids market was reported at US$ 8.11 billion in 2005, that increased at a CAGR of 16.22% to reach US$ 17.19 billion in 2010, during the period (2005-2010).	56
Exhibit 10. Unnatural Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	56
Exhibit 11. Unnatural Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	57
Exhibit 12. Unnatural Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	58
3.3 (I) United States Unnatural Amino Acids Market	58
3.3 (II) Canadian Unnatural Amino Acids Market	58
Exhibit 13. List of Major North American Unnatural Amino Acids Companies	58
3.4 European Unnatural Amino Acids Market	59
Exhibit 14. Unnatural Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	59
Exhibit 15. Unnatural Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	60
Exhibit 16. Unnatural Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	61
3.4 (I) United Kingdom Unnatural Amino Acids Market	61
3.4 (II) German Unnatural Amino Acids Market	61
3.4 (III) Swiss Unnatural Amino Acids Market	61
3.4 (IV) Italian Unnatural Amino Acids Market	61
3.4 (V) Dutch Unnatural Amino Acids Market	61
3.4 (VI) Russian Unnatural Amino Acids Market	62
Exhibit 17. List of Major European Unnatural Amino Acids Companies	62
3.5 Asia-Pacific Unnatural Amino Acids Market	63
Asia-Pacific Unnatural Amino Acids market was reported at US$ 4.7 billion in 2005 that increased at a CAGR of 17.40% to reach around US$ 10.6 billion in 2010, during the analysis period (2005-2010).	63
Exhibit 18. Unnatural Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	63
Exhibit 19. Unnatural Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	64
Exhibit 20. Unnatural Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	65
3.5 (I) Chinese Unnatural Amino Acids Market	65
3.5 (II) Japanese Unnatural Amino Acids Market	65
3.5 (III) Indian Unnatural Amino Acids Market	65
Exhibit 21. List of Unnatural Amino Acids and their Import Prices to India	66
Exhibit 22. List of Unnatural Amino Acid and their Local Prices	66
3.5 (IV) South Korean Unnatural Amino Acids Market	67
3.5 (VI) Australian Unnatural Amino Acids Market	68
Exhibit 23. List of Major Asia-Pacific Unnatural Amino Acids Companies	68
3.6 Rest of World Unnatural Amino Acids Market	69
Exhibit 24. Unnatural Amino Acids - Rest of World Historic Value Market (2005-2010) for Brazil, South Africa, Israel and Other Countries in US$ Million	69
Exhibit 25. Unnatural Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) Brazil, South Africa, Israel and Other Countries in US$ Million	70
Exhibit 26. Unnatural Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) for Brazil, South Africa, Israel and Other Countries	71
3.6 (I) Brazilian Unnatural Amino Acids Market	71
3.6 (II) South African Unnatural Amino Acids Market	71
3.6 (III) Israeli Unnatural Amino Acids Market	71
3.7 Unnatural Amino Acids – Major Competitor Profiles	72
AbbVie, Inc. (USA)	72
ACS Dobfar SpA (Italy)	73
Æterna Zentaris, Inc. (Canada)	75
Ajinomoto Co., Inc. (Japan)	75
Amatek Chemical Co., Ltd. (Hong Kong)	76
AminoLogics Co. Ltd. (South Korea)	77
AnaSpec, Inc. (USA)	78
Aspen Pharmacare Holdings Ltd. (South Africa)	79
AstraZeneca plc (UK)	79
Bajaj Healthcare Ltd. (India)	81
BASF SE (Germany)	81
Bayer CropScience AG (Germany)	82
Biological E Ltd. (India)	83
Biovet SA (Spain)	84
Central Life Sciences (USA)	85
Corden Pharma International GmbH (Germany)	87
CSPC Pharmaceutical Group Limited (Hong Kong)	88
C-TRI Co., Ltd. (South Korea)	90
Divis Laboratories Ltd. (India)	91
Donboo Amino Acid Co., Ltd. (China)	92
DSM Sinochem Pharmaceuticals (Singapore)	93
EMD Millipore (USA)	94
EMD Serono, Inc. (USA)	105
Enzo Life Sciences, Inc. (USA)	105
Evonik Industries AG (Germany)	106
GlaxoSmithKline plc (UK)	108
Hanmi Pharmaceutical Co., Ltd. (South Korea)	110
Harbin Pharmaceutical Group Co., Ltd. (China)	112
Hovid Berhad (Malaysia)	112
IRIS Biotech GmbH (Germany)	114
Kyowa Hakko Bio Co., Ltd. (Japan)	150
Lek d.d. (Slovenia)	151
Lunan Pharmaceutical Group Corporation (China)	152
Lupin Pharmaceuticals, Inc. (USA)	153
Mimotopes Pty. Ltd. (Australia)	154
MP Biomedicals, LLC (USA)	154
Nagase & Co., Ltd. (Japan)	164
Norbrook Laboratories Ltd. (UK)	165
Novartis AG (Switzerland)	167
Orchid Chemicals & Pharmaceuticals Ltd. (India)	167
Pfizer, Inc. (USA)	171
PolyPeptide Group (The) (Denmark)	172
Ranbaxy Laboratories Ltd. (India)	172
Sandoz International GmbH (Germany)	173
Sanofi SA (France)	175
Sekisui Medical Co., Ltd. (Japan)	176
Shanghai Hanhong Chemical Co., Ltd. (China)	179
Shanghai HC Biotech Co., Ltd. (China)	179
Shanghai PanQi Biochem Tech Co., Ltd. (China)	181
Sigma-Aldrich Co. LLC (USA)	182
Synthetech, Inc. (USA)	184
Tocris Bioscience (USA)	185
Topsun International Group Co., Ltd. (China)	185
Unibiochem Co., Ltd. (China)	186
United Laboratories International Holdings Limited (The) (Hong Kong)	188
Venus Remedies Ltd. (India)	190
Xeno Pharmaceuticals Phils, Inc. (Philippines)	192
Zhangjiagang Huachang Pharmaceutical Co., Ltd. (China)	192
3.8 Major Activities in Unnatural Amino Acids Market	193
Yungjin Pharmaceuticals Cooperative Limited Expands Business in China	193
Venus Remedies Limited to Venture Italy	193
Ceftobiprole, the Antibiotic of Basilea, Granted Regulatory Approval for Pneumonia in Europe	193
Cephalosporin Oral Solid Certified With EU-GMP	194
DSM Sinochem Pharmaceuticals Launches Puriclor® (cefaclor), the Latest Member of its Unique Enzymat	194
Abbott Diversifies Research-Based Pharmaceuticals Business	194
Pernix Therapeutics Acquires Somaxon Pharmaceuticals	195
BPI Introduces New and Advanced Pre-Workout PUMP-HD™	195
Orchid Chemicals and Pharmaceuticals to withdraw from its Chinese Joint Venture	195
Actavis Completely Acquired by Watson	195
Pfizer Completes Sale of Nutrition Business to Nestlé	196
Sagent Pharmaceuticals Launches Nafcillin for Injection, USP	196
Ajinomoto Co. Enters into a JV with Genexine Co. Ltd., for Production and Marketing of Serum Free Medium for Biopharmaceuticals	196
Actavis - Watson New Name for Global Operations	196
Ajinomoto Co. Establishes a JV in Indonesia to Produce Cosmetic Components	197
Kyowa Hakko Bio to Set Up a New Amino Acid Producing Unit as well as Subsidiary plant in Thailand	197
Pfizer and Hisun Launch Hisun-Pfizer Pharmaceuticals Co., Ltd	198
Bayer Crop Science Acquires Agraquest	198
European Commission Approves ZINFORO™ (ceftaroline fosamil) for Adult Patients with Serious Skin Infections or Community Acquired Pneumonia	198
Orchid Pharma Enters into a Business Transfer Agreement (BTA) with Hospira to transfer its Penicillin and Penem API business and its API Unit in Aurangabad	198
Sagent Pharmaceuticals Launches Oxacillin for Injection, USP	199
Derma Sciences Acquires Global Long-Term Exclusive Rights to NIMBUS Technology from Quick-Med Technologies	199
Stauber Performance Ingredients Acquires Florida based Pharmline	199
Zinforo (ceftaroline fosamil) Receives Positive CHMP Opinion in the European Union for the Treatment of Patients with Serious Skin Infections or Community Acquired Pneumonia	200
Sigma Aldrich Takes Over Research Organics Materials	200
Pernix Therapeutics Acquires Cypress Pharmaceuticals and Hawthorn Pharmaceuticals	200
Manufacture of Non-Natural Amino acids and ARCA	200
Evonik Plans to Setup Methionine Production Plant in Singapore	200
Cubist Pharmaceuticals Acquires Adolor Corporation	201
Actavis Takes Over Dutch Company PharmaPack International	201
Natural Alternatives International Receives New US Beta-Alanine Patent Protecting CarnoSyn® Products	201
Hospira Launches Imipenem- cilastatin for Injection and IV	201
Baxter Acquires Baxa Corporation	202
Enamine Launches Peptide Synthesis Laboratory	202
Astra Zeneca and Forest Labs Initiates Phase III Clinical Trials for Ceftazidime /Avibactam for Treatment of Gram-Negative Bacterial Infections	202
Bristol-Myers Squibb Enters into Collaboration with Ambrx Announce for Novel Biologics Programs in Diabetes and Heart Failure	202
Aurobindo Pharma and Russia based Diod Establishes Joint Venture to Manufacture and Market Generic Drugs in Russia	203
Alkermes Inc., Merges with Elan Drug Technologies	203
Kyowa Hakko Kirin Submits Additional Indication Application for Synthesized Penicillin "PASETOCIN®"	203
AMINO GmbH and Danisco A/S Enters into Cooperation Agreement Encompassing Fermentation of Amino Acids	204
Kyowa Hakko Bio Announces Commercial Production of cis-4-Hydroxy-L-proline	204
Sanofi-Aventis Completes Acquisition of Genzyme Corporation	204
Alcon and Novartis Complete Merger to create New Alcon Division with Global Leadership in Eye Care	205
Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	205
Dr. Reddy’s Acquires GSK’s US Penicillin Facility	206
Reanal in Association with Celtic Catalysts Provides Difficult-to-Make Amino Acids for Peptide Market	206
Genzyme Completes Sale of Diagnostic Products Business to Sekisui Chemical Co.	206
Sutro Biopharma Enters into Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide- Based Therapeutics	206
Nutrena® Brand of Cargill Launches NatureWise® Range of Natural Poultry Feeds and Country Feeds® for Poultry	207
Bristol-Myers Squibb and Sanofi-Aventis Receive Approval for Pediatric Exclusivity for PLAVIX(R) (Clopidogrel Bisulfate) from the US FDA	208
Aspen Acquires Sigma's Pharmaceutical Business	208
Albion Obtains Patent for Hypoallergenic Metal Chelates	208
Grace Buys Stake in Synthetech	209
Venus Remedies Attains GMP Certification from Saudi Arabia (SFDA)	209
Pfizer through King Pharma Acquisition Widens the Company’s Presence in the Pain Drugs Market	210
USDA-ARS Enters into Partnership with Ajinomoto	210
Nestlé Performance Nutrition unveils the New PowerBar® Elite Series HIGH INTENSITY dietary supplement	210
VENUS attains EU patent for the investigated drug - SULBACTOMAX	211
Abbott Launches EAS Peak™ with P3 Technology	211
Abbott Introduces New Nutritional Shakes	212
Venus Pharma Receives Market Approval for the Proprietary Carbapenem Injection in Portugal	213
Merck KGaA Acquires Millipore and Forms New EMD Millipore Division	213
FDA Approves Hospira’s Generic Version of Antibiotic Merrem	213
Arbuckle’s Planet Rice Record Swelling Sales	214
The US Patent and Trademark Office Issues Notice of Allowance for MultiStat® Group of Compounds of Quick-Med Technologies	214
Orchid Acquires Karalex Pharma, LLC	215
Low-cost Drug to Save Thousands of Accident Victims	215
Ethical Naturals Develops AlphaWave™, a GRAS Approved L-Theanine	215
US FDA Approves Aurobindo Pharma’s Ceftazidime for Injection	216
Strides Arcolab Obtains FDA Approval for Bacitracin Injections	216
First Generic Version of Augmentin XR Launched in the US by Sandoz	216
Victory Pharma Acquires Assets of MiddleBrook Pharmaceutical for US$ 17.1 Million	217
FDA Approves DUPLEX® System of B.Braun for Administration of Cefepime	217
Ceftobiprole Sales to be Discontinued in Canada	217
Health Canada Approves Cefprozil Tablets & Powder for Oral Suspension of Aurobindo	218
MDRNA, Inc. and Pfizer in Joint Research Study	218
Novel Peptide Synthesis and Manufacturing Services Launched by Ajinomoto AminoSciences	218
AstraZeneca Acquires Novexel	219
FDA Approves Florida Based Cephalosporin Manufacturing Facility of GeoPharma	220
Pernix Therapeutics Holdings Acquires CEDAX, an Oral Third-Generation Cephalosporin	220
Venus Remedies Obtains Patent for SULBACTOMAX	220
Studies Indicate Ineffectiveness of Starlix, the Diabetes Drug of Novartis	221
Hospira Acquires Injectables Formulation Business of Orchid	221
Mefoxin® (cefoxitin injection) Frozen Premix IV Solution Launched by Bioniche Pharma	221
Antibiotics Prices in India likely to Increase Up to 50%	222
Chinese SFDA Approves Penicillin Manufacturing Facility of Suzhou Erye Pharmaceutical	222
Queensland Institute of Medical Research Awards Major Peptide Supply Contract to Mimotopes for Malaria Vaccine Research	223
AminoLogics Uses Novel Chiral Technology (ARCA) for Unnatural Amino Acids	223
Æterna Zentaris Terminates Agreement to Develop, Commercialize and License Cetrorelix in Benign Prostatic Hyperplasia with Sanofi-Aventis	223
Cubist Pharmaceuticals Formally Acquires Calixa Therapeutics	224
La Jolla Institute Awards Peptide Library Supply Contract to Screen Dengue & Tuberculosis Pathogens to Mimotopes	224
Drug Precursor for Cardiovascular Diseases Treatment Developed at USM	224
Venus Remedies Obtains South African Patent for Potentox	225
AnaSpec Acquired by Eurogentec	225
Online Peptide Superstore Launched by Mimotopes	226
American Peptide Company Creates Research & Development Division	226
AnaSpec Appoints Distributor in South Africa	227
Generic Nateglinide for Diabetes Launched in the US by Dr Reddy’s	227
Steri-Pharma Acquires Cephalosporin Manufacturing Facility from Hanford Pharmaceuticals	227
Swissmedic Approves Aurobindo Pharma’s Cefepime for Injection	227
AstraZeneca and Forest in Ceftaroline Co-development and Commercialization Agreement	228
FDA Declares Cefepime Appropriate	228
Penicillin G Potassium for Injection, USP, of APP Pharmaceuticals Approved by FDA	228
Generic Version of Vantin® Launched in the US by Sandoz	229
Venus Remedies Obtains First Product Patent in South Korea	229
Evonik Plans Substantial Methionine Manufacturing Capacity Expansion	229
AnaSpec Appoints Distributor for Lithuania & Latvia	230
Piperacillin/Tazobactam for Injection Launched in the UK by Hospira	230
ClearPoint™ Peptides of AnaSpec Bestowed Best New Product Award	230
Pfizer and Aurobindo Pharma Expand agreement from 5 Drugs to 44 drugs	230
AnaSpec Offers to Provide Custom Synthesis of Stapled Helical Peptides	231
FIRMAGON® (degarelix) of Ferring Pharmaceuticals Approved by European Commission as Prostate Cancer Treatment	231
Lundbeck Takes Over Ovation Pharmaceuticals	231
Sagent Pharmaceuticals Launches Cefazolin for Injection, USP in 500mg Single-dose Vial to Expand Cefazolin Product Range	232
AnaSpec Appoints BioPike as Distributor for China	232
CPC Scientific and Sigma-Aldrich in PEPscreen® Custom Peptide Libraries Distribution Agreement	232
FDA/NCIMS Approves BetaStar® Dairy Antibiotic Test of Neogen	233
AnaSpec Appoints Yope Biotechnology as Distributor	233
FDA Approves Generic Version of Augmentin Suspension	233
Zevtera Approved in Switzerland as Complicated Skin & Soft Tissue Infection Treatment	233
Evonik Enhances Methionine Production Capacity	234
AnaSpec and Shanghai Universal Biotech in Distribution Agreement	234
FDA Grants US Marketing Approval to Ceftazidime Injection of Wockhardt	234
Wockhardt Obtains Marketing Approval for Ceftazidime Injections from FDA	235
Zosyn®, an Injectable Semi-synthetic Antibiotic & ß-lactamase Inhibitor Combination Launched in Japan	235
Taisho Launches of Zosyn® in Japan	235
Merck and Orchid in Anti-infection Drugs Development Collaboration	236
AnaSpec and Biocore in Distribution Agreement	236
Venus Remedies Launches its Fourth Research Product	236
Injectables Ceftriaxone and Cefuroxime Launched by Sagent Pharmaceuticals	237
Cubist to Promote Merrem IV of AstraZeneca in the US	237
Novartis Acquires Protez Pharmaceuticals Along With Rights to Hospital Antibiotic in Clinical Development	237
Lupin Launches Ramipril Capsules	237
Inquiries Follow Nagase in Concurrence with Reinforcement of Unnatural Amino Acids	238
Protez Initiates Phase II Clinical Trials for PZ-601 in Infectious Diseases	238
Achillion and FOB Synthesis to Develop Carbapenem Compounds in Collaboration	238
Novartis Acquires Stake in Alcon	239
Strategic Acquisition by Aurobindo Pharma for Expansion in Europe	239
AOAC Approves BetaStar® Dairy Antibiotic Test of Neogen	239
FDA Grants Manufacturing & Marketing Approval of Cefuroxime Axetil to Ranbaxy	240
Cefuroxime Axetil for Oral Suspension of Ranbaxy Approved in the US	240
Amoxicillin of MiddleBrook Approved by FDA for Pharyngitis/Tonsillitis in Adults and Adolescents	240
DSM Anti-Infectives and Arch Pharmalabs in Partnership Agreement	241
US FDA Approves Cefpodoxime Proxetil ANDA of Orchid	241
NeoMPS Acquired by PolyPeptide Group	241
Eli Lilly Sells Indian Marketing Rights of Antibiotic Distaclor® (Cefaclor) to Pharmalink	242
FDA Approves Aurobindo Pharma’s Cefazolin for Injection USP	242
Advancis Pharmaceutical Corporation Renamed MiddleBrook Pharmaceuticals, Inc	242
Lupin Obtains FDA Approval for Cefdinir for Oral Suspension, 250mg/ 5ml, to Launch Entire Product Range	242
Bachem in Expanded Peptide Production Co-operation with Immatics	242
Æterna Zentaris Reclaims Exclusive Global Rights (Ex-Japan) from Solvay for Cetrorelix	243
Charm Sciences Launches ROSA® SL3™	243
FDA Approves Suprax of Lupin Pharmaceuticals	243
FDA Grants US Marketing Approval for Complete Range of Ceftriaxone Antibiotic Injection to Wockhardt	244
FDA Grants Marketing Approval to Wockhardt for Complete Range of Ceftriaxone Antibiotic Injections	244
Cephalosporin Injectable Manufacturing Facility Approved	244
Orchid in Licensing and Distribution Agreement with Actavis for Marketing of Cephalosporin Formulations in Entire Europe	244
FDA Grants Marketing Approval for Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, to Ranbaxy	245
FDA Marketing Approval to Ranbaxy for Amoxicillin and Clavulanate Potassium for Oral Suspension USP	245
FDA Grants Manufacturing and Marketing Approval of Cefprozil Anti-infective Tablets to Ranbaxy Laboratories	246
Æterna Zentaris Launches Cetrotide® (Cetrorelix) in Japan for In-Vitro Fertilization	246
FDA Approves Ceftriaxone 10gm Vials of Lupin	246
FDA Marketing Approval to Wockhardt for Cefotaxime Injection	246
Advancis Launches Keflex 750mg Capsules	247
Carbapenem Antibiotic Finibax 0.25g IV Solution Kit (Doripenem Hydrate) Launched in Japan by Shionogi	247
Brookwood and Genzyme in an Expansive Drug Delivery Collaboration	247
FDA Approves Cephalexin Capsules of Aurobindo Pharma	247
Polymer Launches New Resin for Solid-phase Synthesis of Resin-Bound Unnatural Amino Acids	248
US FDA Approves Ceftriaxone Vials of Orchid	248
FDA Approves Baxter’s Frozen Premixed Ceftriaxone Injection in Ready-to-Use Containers	248
Advancis Launches Keflex® Powder for Oral Suspension in the US	248
Ranbaxy Introduces Chewable Cephalosporin Tablet	249
3.9 Unnatural Amino Acids – Market Analysis by Type	250
Type Analysis	250
Exhibit 27. Unnatural Amino Acids – Global Historic Value Market (2005 - 2010) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other in US$ Million	251
Exhibit 28. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other in US$ Million	252
Exhibit 29. Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other	253
Type Analysis by Region	255
3.9.1 D-Amino Acid Derivatives	255
3.9.1.1 Global D-Amino Acid Derivatives Market	256
Exhibit 30. D-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	256
Exhibit 31. D-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	257
Exhibit 32. D-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	258
D-Amino Acids and Derivatives	259
Exhibit 33. D-Amino Acids and Derivatives - Global Production Market Estimations and Predictions (2005-2020) in Metric Tons	259
D-Phenylglycine and p-hydroxy-D-phenylglycine	260
Exhibit 34. D-Phenylglycine and p-hydroxy-D-phenylglycine - Global Production Market Estimations and Predictions (2005-2020) in Metric Tons	260
p-hydroxy-D-phenylglycine	261
Exhibit 35. p-hydroxy-D-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	261
D-phenylglycine	262
Exhibit 36. D-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	262
D-2-Chlorophenylglycine	263
Exhibit 37. D-2-Chlorophenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	263
D-Penicillamine	264
Exhibit 38. D-Penicillamine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	264
D-2-Naphthylalanine	265
Exhibit 39. D-2-Naphthylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	265
Exhibit 40. List of Global D - Amino Acids Derivatives Companies	266
3.9.1.2 North American D-Amino Acid Derivatives Market	267
Exhibit 41. D-Amino Acid Derivatives - North American Historic Value Market (2005 - 2010) by Country for United States and Canada in US$ Million	267
Exhibit 42. D-Amino Acid Derivatives - North American Value Market Estimations & Predictions (2011 - 2020) by Country for United States and Canada in US$ Million	268
Exhibit 43. D-Amino Acid Derivatives - North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	269
3.9.1.2 (I) United States D-Amino Acid Derivatives Market	269
3.9.1.2 (II) Canadian D-Amino Acid Derivatives Market	269
3.9.1.3 European D-Amino Acid Derivatives Market	270
Exhibit 44. D-Amino Acid Derivatives - European Historic Value Market (2005 - 2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	270
Exhibit 45. D-Amino Acid Derivatives - European Value Market Estimations & Predictions (2011 - 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	271
Exhibit 46. D-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2012) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	272
3.9.1.3 (I) United Kingdom D-Amino Acid Derivatives Market	272
3.9.1.3 (II) German D-Amino Acid Derivatives Market	272
3.9.1.3 (III) Swiss D-Amino Acid Derivatives Market	272
3.9.1.3 (IV) Italian D-Amino Acid Derivatives Market	272
3.9.1.3 (V) Dutch D-Amino Acid Derivatives Market	273
3.9.1.3 (VI) Russian D-Amino Acid Derivatives Market	273
3.9.1.4 Asia-Pacific D-Amino Acid Derivatives Market	274
Exhibit 47. D-Amino Acid Derivatives - Asia-Pacific Historic Value Market (2005 - 2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	274
Exhibit 48. D-Amino Acid Derivatives - Asia-Pacific Value Market Estimations & Predictions (2011 - 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	275
Exhibit 49. D-Amino Acid Derivatives - Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	276
3.9.1.4 (I) Chinese D-Amino Acid Derivatives Market	276
3.9.1.4 (II) Japanese D-Amino Acid Derivatives Market	276
3.9.1.4 (III) Indian D-Amino Acid Derivatives Market	276
3.9.1.4 (IV) South Korean D-Amino Acid Derivatives Market	276
3.9.1.4 (V) Australian D-Amino Acid Derivatives Market	276
3.9.1.5 Rest of World D-Amino Acid Derivatives Market	277
Exhibit 50. D-Amino Acid Derivatives – Rest of World Historic Value Market (2005 - 2010) by Country Brazil, South Africa, Israel and Other Countries in US$ Million	277
Exhibit 51. D-Amino Acid Derivatives – Rest of World Value Market Estimations & Predictions (2011 - 2020) by Country Brazil, South Africa, Israel and Other Countries in US$ Million	278
Exhibit 52. D-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country Brazil, South Africa, Israel and Other Countries	279
3.9.1.5 (I) Brazilian D-Amino Acid Derivatives Market	279
3.9.1.5 (II) South African D-Amino Acid Derivatives Market	279
3.9.1.5 (III) Israeli D-Amino Acid Derivatives Market	279
3.9.2 L-Amino Acid Derivatives	280
3.9.2.1 Global L-Amino Acid Derivatives Market	280
Exhibit 53. L-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	280
Exhibit 54. L-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	281
Exhibit 55. L-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	282
L-DOPA	283
Exhibit 56. L-Dopa - Global Value Market Estimations and Predictions (2005-2020) in US$ Billion	283
L-p-hydroxy-phenylglycine	284
Exhibit 57. L-p-hydroxy-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	284
L-Homophenylalanine	285
Exhibit 58. L-Homophenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	285
L-homoalanine	286
Exhibit 59. L-homoalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	286
Acetyl-L-Carnitine	287
Exhibit 60. Acetyl-L-Carnitine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	287
Exhibit 61. List of Global L - Amino Acids Derivatives Companies	288
3.9.2.2 North American L-Amino Acid Derivatives Market	289
Exhibit 62. L-Amino Acid Derivatives - North American Historic Value Market (2005 - 2010) by Country for United States and Canada in US$ Million	289
Exhibit 63. L-Amino Acid Derivatives - North American Value Market Estimations & Predictions (2011 - 2020) by Country for United States and Canada in US$ Million	290
Exhibit 64. L-Amino Acid Derivatives - North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	291
3.9.2.2 (I) United States L-Amino Acid Derivatives Market	291
3.9.2.2 (II) Canadian L-Amino Acid Derivatives Market	291
3.9.2.3 European L-Amino Acid Derivatives Market	292
Exhibit 65. L-Amino Acid Derivatives - European Historic Value Market (2005 - 2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	292
Exhibit 66. L-Amino Acid Derivatives - European Value Market Estimations & Predictions (2011 - 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	293
Exhibit 67. L-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	294
3.9.2.3 (I) United Kingdom L-Amino Acid Derivatives Market	294
3.9.2.3 (II) German L-Amino Acid Derivatives Market	294
3.9.2.3 (III) Swiss L-Amino Acid Derivatives Market	294
3.9.2.3 (IV) Italian L-Amino Acid Derivatives Market	294
3.9.2.3 (V) Dutch L-Amino Acid Derivatives Market	295
3.9.2.3 (VI) Russian L-Amino Acid Derivatives Market	295
3.9.2.4 Asia-Pacific L-Amino Acid Derivatives Market	296
Exhibit 68. L-Amino Acid Derivatives - Asia-Pacific Historic Value Market (2005 - 2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	296
Exhibit 69. L-Amino Acid Derivatives - Asia-Pacific Value Market Estimations & Predictions (2011 - 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	297
Exhibit 70. L-Amino Acid Derivatives - Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	298
3.9.2.4 (I) Chinese L-Amino Acid Derivatives Market	298
3.9.2.4 (II) Japanese L-Amino Acid Derivatives Market	298
3.9.2.4 (III) Indian L-Amino Acid Derivatives Market	298
3.9.2.4 (IV) South Korean L-Amino Acid Derivatives Market	298
3.9.2.4 (V) Australian L-Amino Acid Derivatives Market	298
3.9.2.5 Rest of World L-Amino Acid Derivatives Market	299
Exhibit 71. L-Amino Acid Derivatives – Rest of World Historic Value Market (2005 - 2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	299
Exhibit 72. L-Amino Acid Derivatives – Rest of World Value Market Estimations & Predictions (2011 - 2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	300
Exhibit 73. L-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	301
3.9.2.5(I) Brazilian L-Amino Acid Derivatives Market	301
3.9.2.5 (II) South African L-Amino Acid Derivatives Market	301
3.9.2.5 (III) Israeli L-Amino Acid Derivatives Market	301
3.9.3 Cyclic Amino Acids	302
3.9.3.1 Global Cyclic Amino Acids Market	302
Exhibit 74. Cyclic Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	302
Exhibit 75. Cyclic Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	303
Exhibit 76. Cyclic Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	304
D-CycloSerine	305
Exhibit 77. D-Cycloserine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	305
3.9.3.2 North American Cyclic Amino Acids Market	306
Exhibit 78. Cyclic Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	306
Exhibit 79. Cyclic Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	307
Exhibit 80. Cyclic Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	308
3.9.3.2 (I) United States Cyclic Amino Acid Derivatives Market	308
3.9.3.2 (II) Canadian Cyclic Amino Acid Derivatives Market	308
3.9.3.3 European Cyclic Amino Acids Market	309
Exhibit 81. Cyclic Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	309
Exhibit 82. Cyclic Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	310
Exhibit 83. Cyclic Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	311
3.9.3.3 (I) United Kingdom Cyclic Amino Acid Derivatives Market	311
3.9.3.3 (II) German Cyclic Amino Acid Derivatives Market	311
3.9.3.3 (III) Swiss Cyclic Amino Acid Derivatives Market	311
3.9.3.3 (IV) Italian Cyclic Amino Acid Derivatives Market	311
3.9.3.3 (V) Dutch Cyclic Amino Acid Derivatives Market	311
3.9.3.3 (VI) Russian Cyclic Amino Acid Derivatives Market	311
3.9.3.4 Asia-Pacific Cyclic Amino Acids Market	312
Exhibit 84. Cyclic Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	312
Exhibit 85. Cyclic Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	313
Exhibit 86. Cyclic Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	314
3.9.3.4 (I) Chinese Cyclic Amino Acid Derivatives Market	314
3.9.3.4 (II) Japanese Cyclic Amino Acid Derivatives Market	314
3.9.3.4 (III) Indian Cyclic Amino Acid Derivatives Market	314
3.9.3.4 (IV) South Korean Cyclic Amino Acid Derivatives Market	314
3.9.3.4 (V) Australian Cyclic Amino Acid Derivatives Market	314
3.9.3.5 Rest of World Cyclic Amino Acids Market	315
Exhibit 87. Cyclic Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	315
Exhibit 88. Cyclic Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	316
Exhibit 89. Cyclic Amino Acids – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	317
3.9.3.5 (I) Brazilian Cyclic Amino Acid Derivatives Market	317
3.9.3.5 (II) South African Cyclic Amino Acid Derivatives Market	317
3.9.3.5 (III) Israeli Cyclic Amino Acid Derivatives Market	317
3.9.4 β-Amino Acid Derivatives	318
3.9.4.1 Global β-Amino Acid Derivatives Market	318
Exhibit 90. β-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	318
Exhibit 91. β-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	319
Exhibit 92. β-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	320
β-Amino Alcohols	321
Exhibit 93. β-Amino Alcohols - Global Value Market Estimations & Predictions (2005-2020) in US$ Million	321
Exhibit 94. List of Global β-Amino Acids Derivatives Companies	322
3.9.4.2 North American β-Amino Acid Derivatives Market	323
Exhibit 95. β-Amino Acid Derivatives – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	323
Exhibit 96. β-Amino Acid Derivatives – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	324
Exhibit 97. β-Amino Acid Derivatives – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	325
3.9.4.2 (I) United States β-Amino Acid Derivatives Market	325
3.9.4.2 (II) Canadian β-Amino Acid Derivatives Market	325
3.9.4.3 European β-Amino Acid Derivatives Market	326
Exhibit 98. β-Amino Acid Derivatives β-Amino Acid Derivatives – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	326
Exhibit 99. β-Amino Acid Derivatives – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	327
Exhibit 100. β-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	328
3.9.4.3 (I) United Kingdom β-Amino Acid Derivatives Market	328
3.9.4.3 (II) German β-Amino Acid Derivatives Market	328
3.9.4.3 (III) Swiss β-Amino Acid Derivatives Market	328
3.9.4.3 (IV) Italian β-Amino Acid Derivatives Market	328
3.9.4.3 (V) Dutch β-Amino Acid Derivatives Market	329
3.9.4.3 (VI) Russian β-Amino Acid Derivatives Market	329
3.9.4.4 Asia-Pacific β-Amino Acid Derivatives Market	330
Exhibit 101. β-Amino Acid Derivatives – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	330
Exhibit 102. β-Amino Acid Derivatives – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	331
Exhibit 103. β-Amino Acid Derivatives – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	332
3.9.4.4 (I) Chinese β-Amino Acid Derivatives Market	332
3.9.4.4 (II) Japanese β-Amino Acid Derivatives Market	332
3.9.4.4 (III) Indian β-Amino Acid Derivatives Market	332
3.9.4.4 (IV) South Korean β-Amino Acid Derivatives Market	332
3.9.4.4 (V) Australian β-Amino Acid Derivatives Market	332
3.9.4.5 Rest of World β-Amino Acid Derivatives Market	333
Exhibit 104. β-Amino Acid Derivatives - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	333
Exhibit 105. β -Amino Acid Derivatives - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	334
Exhibit 106. β-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	335
3.9.4.5 (I) Brazilian β-Amino Acid Derivatives Market	335
3.9.4.5 (II) South African β-Amino Acid Derivatives Market	335
3.9.4.5 (III) Israeli β-Amino Acid Derivatives Market	335
3.9.5 D-Amino Acids	336
3.9.5.1 Global D-Amino Acids Market	336
Exhibit 107. D-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	336
Exhibit 108. D-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	337
Exhibit 109. D-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	338
D-Alanine	339
Exhibit 110. D-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	339
D-Arginine	340
Exhibit 111. D-Arginine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	340
D-Aspartic Acid	341
Exhibit 112. D-Aspartic Acid - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	341
D-Cysteine	342
Exhibit 113. D-Cysteine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	342
D-Leucine	343
Exhibit 114. D-Leucine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	343
D-Lysine	344
Exhibit 115. D-Lysine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	344
D-Phenylalanine	345
Exhibit 116. D-Phenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	345
D-Serine	347
Exhibit 117. D-Serine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	347
D-Threonine	348
Exhibit 118. D-Threonine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	348
D-Tryptophan	349
Exhibit 119. D-Tryptophan - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	349
D-Tyrosine	350
Exhibit 120. D-Tyrosine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	350
D-Valine	351
Exhibit 121. D-Valine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	351
D-Glutamic Acid	352
Exhibit 122. D-Glutamic Acid - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	352
D-Proline	353
Exhibit 123. D-Proline - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	353
D-Histidine	354
Exhibit 124. D-Histidine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	354
Exhibit 125. List of Global D-Amino Acids Companies	355
3.9.5.2 North American D-Amino Acids Market	356
Exhibit 126. D-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	356
Exhibit 127. D-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	357
Exhibit 128. D-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	358
3.9.5.2 (I) United States D-Amino Acids Market	358
3.9.5.2 (II) Canadian D-Amino Acids Market	358
3.9.5.3 European D-Amino Acids Market	359
Exhibit 129. D-Amino Acids D-Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	359
Exhibit 130. D-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	360
Exhibit 131. D-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	361
3.9.5.3 (I) United Kingdom D-Amino Acids Market	361
3.9.5.3 (II) German D-Amino Acids Market	361
3.9.5.3 (III) Swiss D-Amino Acids Market	361
3.9.5.3 (IV) Italian D-Amino Acids Market	361
3.9.5.3 (V) Dutch D-Amino Acids Market	361
3.9.5.3 (VI) Russian D-Amino Acids Market	361
3.9.5.4 Asia-Pacific D-Amino Acids Market	362
Exhibit 132. D-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	362
Exhibit 133. D-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	363
Exhibit 134. D-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	364
3.9.5.4 (I) Chinese D-Amino Acids Market	364
3.9.5.4 (II) Japanese D-Amino Acids Market	364
3.9.5.4 (III) Indian D-Amino Acids Market	364
3.9.5.4 (IV) South Korean D-Amino Acids Market	364
3.9.5.4 (V) Australian D-Amino Acids Market	364
3.9.5.5 Rest of World D-Amino Acids Market	365
Exhibit 135. D-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	365
Exhibit 136. D-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	366
Exhibit 137. D-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	367
3.9.5.5 (I) Brazilian D-Amino Acids Market	367
3.9.5.5 (II) South African D-Amino Acids Market	367
3.9.5.5 (III) Israeli D-Amino Acids Market	367
3.9.6 β-Amino Acids	368
3.9.6.1 Global β-Amino Acids Market	368
Exhibit 138. β-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	368
Exhibit 139. β-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	369
Exhibit 140. β-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	370
β-Alanine	371
Exhibit 141. β-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	371
Exhibit 142. List of Global β-Amino Acids Companies	372
3.9.6.2 North American β-Amino Acids Market	373
Exhibit 143. β-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	373
Exhibit 144. β-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	374
Exhibit 145. β-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	375
3.9.6.2 (I) United States β-Amino Acids Derivatives Market	375
3.9.6.2 (II) Canadian β-Amino Acids Derivatives Market	375
3.9.6.3 European β-Amino Acids Market	376
Exhibit 146. β-Amino Acids– European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	376
Exhibit 147. β-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	377
Exhibit 148. β-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	378
3.9.6.3 (I) United Kingdom β-Amino Acids Market	378
3.9.6.3 (II) German β-Amino Acids Market	378
3.9.6.3 (III) Swiss β-Amino Acids Market	378
3.9.6.3 (IV) Italian β-Amino Acids Market	378
3.9.6.3 (V) Dutch β-Amino Acids Market	378
3.9.6.3 (VI) Russian β-Amino Acids Market	378
3.9.6.4 Asia-Pacific β-Amino Acids Market	379
Exhibit 149. β-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	379
Exhibit 150. β-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	380
Exhibit 151. β-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	381
3.9.6.4 (I) Chinese β-Amino Acids Market	381
3.9.6.4 (II) Japanese β-Amino Acids Market	381
3.9.6.4 (III) Indian β-Amino Acids Market	381
3.9.6.4 (IV) South Korean β-Amino Acids Market	381
3.9.6.4 (V) Australian β-Amino Acids Market	381
3.9.6.5 Rest of World β-Amino Acids Market	382
Exhibit 152. β-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	382
Exhibit 153. β-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	383
Exhibit 154. β-Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	384
3.9.6.5 (I) Brazilian β-Amino Acids Market	384
3.9.6.5 (II) South African β-Amino Acids Market	384
3.9.6.5 (III) Israeli β-Amino Acids Market	384
3.9.7 DL-Amino Acids	385
3.9.7.1 Global DL-Amino Acids Market	385
Exhibit 155. DL-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	385
Exhibit 156. DL-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	386
Exhibit 157. DL-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	387
DL-Methionine	388
Exhibit 158. DL-Methionine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	388
DL-Alanine	389
Exhibit 159. DL-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	389
DL-Phenylalanine	390
Exhibit 160. DL-Phenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	390
Exhibit 161. List of Global DL - Amino Acids Companies	391
3.9.7.2 North American DL-Amino Acids Market	393
Exhibit 162. DL-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	393
Exhibit 163. DL-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	394
Exhibit 164. DL-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	395
3.9.7.2 (I) United States DL-Amino Acids Market	395
3.9.7.2 (II) Canadian DL-Amino Acids Market	395
3.9.7.3 European DL-Amino Acids Market	396
Exhibit 165. DL-Amino Acids DL-Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	396
Exhibit 166. DL-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	397
Exhibit 167. DL-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	398
3.9.7.3 (I) United Kingdom DL-Amino Acids Market	398
3.9.7.3 (II) German DL-Amino Acids Market	398
3.9.7.3 (III) Swiss DL-Amino Acids Market	398
3.9.7.3 (IV) Italian DL-Amino Acids Market	398
3.9.7.3 (V) Dutch DL-Amino Acids Market	398
3.9.7.3 (VI) Russian DL-Amino Acids Market	398
3.9.7.4 Asia-Pacific DL-Amino Acids Market	399
Exhibit 168. DL-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	399
Exhibit 169. DL-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	400
Exhibit 170. DL-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	401
3.9.7.4 (I) Chinese DL-Amino Acids Market	401
3.9.7.4 (II) Japanese DL-Amino Acids Market	401
3.9.7.4 (III) Indian DL-Amino Acids Market	401
3.9.7.4 (IV) South Korean DL-Amino Acids Market	401
3.9.7.4 (V) Australian DL-Amino Acids Market	401
3.9.7.5 Rest of World DL-Amino Acids Market	402
Exhibit 171. DL-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	402
Exhibit 172. DL-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	403
Exhibit 173. DL-Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	404
3.9.7.5 (I) Brazilian DL-Amino Acids Market	404
3.9.7.5 (II) South African DL-Amino Acids Market	404
3.9.7.5 (III) Israel DL-Amino Acids Market	404
3.9.8 DL-Amino Acid Derivatives	405
3.9.8.1 Global DL-Amino Acid Derivatives Market	405
Exhibit 174. DL-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	405
Exhibit 175. DL-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	406
Exhibit 176. DL-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	407
Exhibit 177. List of Global DL - Amino Acids Derivatives Companies	407
3.9.8.2 North American DL-Amino Acid Derivatives Market	408
Exhibit 178. DL-Amino Acid Derivatives – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	408
Exhibit 179. DL-Amino Acid Derivatives – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	409
Exhibit 180. DL-Amino Acid Derivatives – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	410
3.9.8.2 (II) United States DL-Amino Acid Derivatives Market	410
3.9.8.2 (II) Canadian DL-Amino Acid Derivatives Market	410
3.9.8.3 European DL-Amino Acid Derivatives Market	411
Exhibit 181. DL-Amino Acid Derivatives DL-Amino Acid Derivatives – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	411
Exhibit 182. DL-Amino Acid Derivatives – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	412
Exhibit 183. DL-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	413
3.9.8.3 (I) United Kingdom DL-Amino Acid Derivatives Market	413
3.9.8.3 (II) German DL-Amino Acid Derivatives Market	413
3.9.8.3 (III) Swiss DL-Amino Acid Derivatives Market	413
3.9.8.3 (IV) Italian DL-Amino Acid Derivatives Market	413
3.9.8.3 (V) Dutch DL-Amino Acid Derivatives Market	413
3.9.8.3 (VI) Russian DL-Amino Acid Derivatives Market	413
3.9.8.4 Asia-Pacific DL-Amino Acid Derivatives Market	414
Exhibit 184. DL-Amino Acid Derivatives – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	414
Exhibit 185. DL-Amino Acid Derivatives – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	415
Exhibit 186. DL-Amino Acid Derivatives – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific	416
3.9.8.4 (I) Chinese DL-Amino Acid Derivatives Market	416
3.9.8.4 (II) Japanese DL-Amino Acid Derivatives Market	416
3.9.8.4 (III) Indian DL-Amino Acid Derivatives Market	416
3.9.8.4 (IV) South Korean DL-Amino Acid Derivatives Market	416
3.9.8.4 (V) Australian DL-Amino Acid Derivatives Market	416
3.9.8.5 Rest of World DL-Amino Acid Derivatives Market	417
Exhibit 187. DL-Amino Acid Derivatives - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	417
Exhibit 188. DL-Amino Acid Derivatives - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million	418
Exhibit 189. DL-Amino Acid Derivatives - Rest of World Value Market Shares (2008. 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries	419
3.9.8.5 (I) Brazilian DL-Amino Acid Derivatives Market	419
3.9.8.5 (II) South African DL-Amino Acid Derivatives Market	419
3.9.8.5 (III) Israeli DL-Amino Acid Derivatives Market	419
3.9.9 Other Unnatural Amino Acids	420
3.9.9.1 Global Other Unnatural Amino Acids Market	420
Exhibit 190. Other Unnatural Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	420
Exhibit 191. Other Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million	421
Exhibit 192. Other Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	422
GABA (Gamma Amino Butyric Acid)	423
Exhibit 193. GABA - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	423
L-Thyroxine	424
Exhibit 194. L-Thyroxine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million	424
3.9.9.2 North American Other Unnatural Amino Acids Market	425
Exhibit 195. Other Unnatural Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million	425
Exhibit 196. Other Unnatural Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million	426
Exhibit 197. Other Unnatural Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada	427
3.9.9.3 European Other Unnatural Amino Acids Market	428
Exhibit 198. Other Unnatural Amino Acids Other Unnatural Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	428
Exhibit 199. Other Unnatural Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million	429
Exhibit 200. Other Unnatural Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe	430
Asia-Pacific Other Unnatural Amino Acids Market	431
Exhibit 201. Other Unnatural Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million	431
Exhibit 202. Othe